Dr. Nathalie C. Zeitouni is a fellowship trained Mohs surgeon who joined the staff of Roswell Park Cancer Institute in 1997, as Chief of Dermatologic Surgery and Director of the Pigmented Lesion Clinic. She earned her medical degree at McGill University, Montreal, Canada in 1993. She completed residency training in Dermatology at Laval University, Quebec City, (1996), and a fellowship in Mohs Micrographic Surgery at the University of Alabama, Birmingham, AL (1997).
Dr. Zeitouni is licensed by New York State and Alabama and is certified by the American Board of Dermatology (1997), Royal College of Physicians of Canada (1997), and the College of Specialists of the Providence of Quebec (1997). She is also Interim Chair, Associate Professor of Dermatology and Director of Dermatologic Surgery Training at the University at Buffalo School of Medicine and Biomedical Sciences. She is the Mohs Surgery Fellowship Director since 2004.
Dr. Zeitouni’s research interests focus on extramammary Paget’s disease; Merkel cell carcinoma and skin cancers in organ transplant patients. She is part of Merkel cell carcinoma Multicenter Interest Group (MMIG) and International Transplant Skin Cancer Collaborative (ITSCC). Her interests also include determining risk factors and developing treatment guidelines for certain rare skin cancers tumors. In 2008, Dr. Zeitouni assumed the role of Director of Photodynamic Therapy (PDT) in Clinical Dermatology.
Dr. Zeitouni is a member of the American Academy of Dermatology, Royal College of Physicians and Surgeons of Canada, American College of Mohs Micrographic Surgery and Cutaneous Oncology, American Academy of Cosmetic Surgery, International Society for Dermatologic Surgery, European Academy of Dermatology and the Buffalo-Rochester Dermatologic Society.
She has authored and co-authored many journal articles and book chapters. She presents abstracts both on a national and international level.